DarioHealth Corp. (DRIO) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, DarioHealth reported revenue of $22.4M, down 17.3% from $27.0M the year before. Net income was -$41.7M (a -186.6% net margin), or $10.12 per diluted share. Gross margin was 56.6% and operating margin was -163.9%. Operating activities generated -$25.9M of cash, leaving -$26.1M of free cash flow. At fiscal year end, DarioHealth held $110.1M in total assets against $42.2M in total liabilities, including $21.8M of cash and equivalents.
Open the full interactive DarioHealth financials → Quarterly statements, key ratios, valuation history and price charts.
DarioHealth Key Stats
| Share Price | $5.54 |
|---|---|
| Market Cap | $51.8M |
| P/E Ratio | 0.5 |
| Revenue YoY Growth | -17.3% |
| 52-Week Range | $5.42 – $16.19 |
| Shares Outstanding | 9.3 million (basic, 2026 Q2) |
DarioHealth Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $7.6M | $20.5M | $27.7M | $20.4M | $27.0M | $22.4M |
| Cost of Goods Sold | $5.1M | $12.4M | $18.0M | $14.4M | $13.8M | $9.7M |
| Gross Profit | $2.5M | $4.0M | $9.7M | $6.0M | $13.3M | $12.7M |
| Operating Income | -$29.9M | -$76.5M | -$56.8M | -$56.2M | -$57.7M | -$36.7M |
| Pre-Tax Income | -$29.4M | -$76.7M | -$62.2M | -$59.4M | -$44.6M | -$41.6M |
| Income Tax | — | $32,000 | $4,000 | $64,000 | -$1.9M | $105,000 |
| Net Income | -$29.4M | -$76.8M | -$62.2M | -$59.4M | -$42.7M | -$41.7M |
| Diluted EPS | $80.20 | $81.40 | $50.80 | $38.60 | $12.20 | $10.12 |
DarioHealth Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $5.0M | $5.2M | $5.6M | $5.2M |
| Net Income | -$10.5M | -$9.0M | -$8.2M | -$7.9M |
| Diluted EPS | $2.96 | -$2.27 | $1.25 | $0.85 |
DarioHealth Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.6M | $35.8M | $49.4M | $36.8M | $27.8M | $21.8M |
| Current Assets | $34.1M | $45.6M | $65.5M | $47.3M | $40.5M | $35.1M |
| Total Assets | $35.4M | $100.8M | $119.2M | $96.4M | $118.9M | $110.1M |
| Current Liabilities | $7.0M | $14.4M | $19.4M | $12.5M | $16.6M | $9.3M |
| Total Long-Term Debt | — | — | $18.1M | $28.5M | $28.9M | $30.7M |
| Total Liabilities | $7.3M | $15.2M | $39.2M | $38.2M | $46.9M | $42.2M |
| Shareholders' Equity | $28.2M | $85.5M | $80.0M | $58.1M | $72.0M | $67.9M |
DarioHealth Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$17.7M | -$50.4M | -$47.8M | -$30.4M | -$38.6M | -$25.9M |
| Cash From Investing | -$1.6M | -$8.1M | -$573,000 | -$547,000 | -$8.9M | -$4.3M |
| Cash From Financing | $27.5M | $65.8M | $61.9M | $18.3M | $38.5M | $24.3M |
| Free Cash Flow | -$17.9M | -$50.7M | -$48.3M | -$31.0M | -$38.7M | -$26.1M |
Figures from DarioHealth's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full DarioHealth financials page for every line item.
DarioHealth Company Profile
| Ticker | DRIO |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | New York, New York |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company |
| SEC CIK | 0001533998 |
Frequently Asked Questions
What was DarioHealth's revenue in fiscal 2025?
DarioHealth (DRIO) reported revenue of $22.4M for fiscal 2025.
What is DarioHealth's annual revenue history?
DarioHealth's annual revenue by fiscal year: 2020: $7.6M; 2021: $20.5M; 2022: $27.7M; 2023: $20.4M; 2024: $27.0M; 2025: $22.4M.
What was DarioHealth's net income in fiscal 2025?
DarioHealth reported net income of -$41.7M for fiscal 2025.
What was DarioHealth's earnings per share (EPS) in fiscal 2025?
DarioHealth's diluted EPS was $10.12 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did DarioHealth generate in fiscal 2025?
DarioHealth generated -$26.1M of free cash flow in fiscal 2025.
What was DarioHealth's revenue last quarter?
In its most recent reported quarter (2026 Q2), DarioHealth reported revenue of $5.2M.
How much debt does DarioHealth have?
DarioHealth reported $30.7M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of DarioHealth are outstanding?
DarioHealth reported a weighted average of 9.3 million basic shares outstanding in 2026 Q2.
What is DarioHealth's market cap?
Based on its latest closing price, DarioHealth (DRIO) has a market capitalization of about $51.8M.
When does DarioHealth's fiscal year end?
DarioHealth's fiscal year end, as registered with the SEC, is December 31.
Where is DarioHealth headquartered?
DarioHealth lists its business address in New York, New York in its SEC filings.